Meneguin Silmara, Aparecido Ayres Jairo
Universidade Estadual Paulista ''Julio de Mesquita Filho'' -UNESP, Botucatu, Brazil,
Invest Educ Enferm. 2014;32(1):97-102. doi: 10.17533/udea.iee.v32n1a11.
To understand the perception of the participants in controlled clinical trials (CCTs) about the informed consent and describe the meaning of their participation in the research.
Qualitative study using the focus group technique. The sample was composed of 19 patients who participated in clinical trials about hypertension and coronary disease in a specialized cardiologic hospital located in the city of Sao Paulo. The methodological framework used was the content analysis.
Some of the participants were aware of the real objective of these studies while others had misperceptions. The reading of the informed consent is not always done and, when it is done, the patient does not understand it. The lack of understanding about the term ''placebo'' was mentioned by some participants. The motivation to participate was the personal benefit.
This study shows that obtaining the informed consent in CCTs is complex and that there is the need to adapt the structure and application of this document, in order to protect the participants and improve the quality of clinical trials performed in the country.
了解参与对照临床试验(CCTs)的受试者对知情同意的认知,并描述他们参与研究的意义。
采用焦点小组技术进行定性研究。样本由19名在圣保罗市一家专业心脏病医院参与高血压和冠心病临床试验的患者组成。所使用的方法框架为内容分析。
一些受试者了解这些研究的真正目的,而另一些人则存在误解。并非总是会阅读知情同意书,即便阅读了,患者也不一定理解。一些受试者提到对“安慰剂”一词缺乏理解。参与的动机是个人利益。
本研究表明,在对照临床试验中获取知情同意是复杂的,有必要调整该文件的结构和应用,以保护受试者并提高在该国进行的临床试验的质量。